Back to search
HIV Viremia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which HIV Viremia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which HIV Viremia trials you may qualify forAntiretroviral therapy or ART blocks HIV replication reducing plasma viral loads to undetectable levels but has no effect on persistently infected cells in the…
Mentor Mothers (MMs) are peer supporters who help pregnant and postpartum women living with HIV (WLHIV) as they receive prevention of mother-to-child transmissi…
The goal of this clinical trial is to find better ways to care for pregnant and postpartum adolescent girls and young women (AGYW) aged 15-24 years with HIV in…
The study aims to increase the reach of the person-centred interpersonal practices by developing and accessing a tailored, scalable, and sustainable approach th…
The objective of antiretroviral therapy (ART) is the maintenance of HIV viral suppression, the optimal condition to prevent disease progression, to optimize imm…
The study will test two behavioral intervention components to identify the combination of the two components that best supports people who inject drugs to achie…
Differentiated service delivery (DSD) is an evidence-based HIV care and treatment model endorsed by the World Health Organization (WHO) that simplifies HIV serv…
The goal of this clinical trial is to learn if valganciclovir works to treat cytomegalovirus (CMV) infection in people with advanced HIV disease. It will also l…
The goal of this study is to determine whether clinical prediction algorithms derived using statistical machine learning methods can be used to improve patient…